Association of intranasal esketamine, a novel 'standard of care' treatment and outcomes in the management of patients with treatment-resistant depression: protocol of a prospective cohort observational study of naturalistic clinical practice.
Gustavo VazquezGilmar GutierrezJoshua RosenblatAyal SchafferJennifer SwainsonGanapathy KarthikeyanNisha RavindranRaymond W LamAndré DoPeter GiacobbeEmily HawkenRoumen MilevPublished in: BMJ open (2022)
Approval to perform this study was obtained through the Health Sciences Research Ethics Board at Queen's University. Findings will be shared among collaborators, through departmental meetings, presented on different academic venues and publishing our manuscript.
Keyphrases
- healthcare
- public health
- clinical practice
- palliative care
- mental health
- depressive symptoms
- quality improvement
- type diabetes
- health information
- metabolic syndrome
- pain management
- risk assessment
- climate change
- physical activity
- deep learning
- affordable care act
- global health
- glycemic control
- adipose tissue
- health promotion
- drug administration